Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-202-2 | CAS number: 63451-47-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study was conducted in accordance with a recognized scientific procedure for determining the developmental toxicity of a test substance when administered repeatedly via inhalation. The study meets national and international scientific standards (OECD 414) and provides sufficient information to support the conclusions regarding the NOAEL demonstrated from the study data.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 999
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- yes
- Remarks:
- clinical observations not followed; individual animal data not reported
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Methacrylic acid
- EC Number:
- 201-204-4
- EC Name:
- Methacrylic acid
- Cas Number:
- 79-41-4
- IUPAC Name:
- methacrylic acid
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Methacrylic acid
- Source: Fluka Chemie AG, Buchs, Switzerland.
- Analytical purity: 98 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: IFFA CREDO Breeding Laboratories (Saint-Germain-sur-L'Arbresle, France)
- Age at study initiation: Sexually mature females; age not specified.
- Weight at study initiation: 180-200 g
- Housing: Mated females were housed singly in clear polycarbonate cages with stainless-steel wire lids and hardwood shavings as bedding. For exposures, the females were transferred to stainless steel wire mesh exposure cages, and the cages were moved into the chambers.
- Diet: Food pellets (UAR Alimentation Villemoisson, France), ad libitum except during exposures
- Water: Filtered tap water, ad libitum except during exposures
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature: 21 ± 2 °C
- Humidity: 50 ± 5 %
- Photoperiod: 12 h dark / 12 h light
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Exposures were conducted in 200 L glass/stainless-steel inhalation chambers with dynamic and adjustable laminar air Now (6-20 m^3/h). In order to prevent any leakage of the test atmospheres, the chambers were maintained at a negative pressure of no more than 3-mm water. The chamber temperature was set at 23 ± 2 °C and the relative humidity at 50 ± 5 %. Vapor generation systems consisted in delivering a constant rate of liquid chemical with an infusion pump at the top of a heated glass column filled with glass beads. Compressed air heated by a glass heater was introduced at the bottom of the glass column in a countercurrent fashion to the liquid flow.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Concentrations were monitored continuously with a Gas Chromatography (GC), and were determined once during each 6 h exposure by collecting the material and analyzing against a standard using GC.
- Details on mating procedure:
- - Impregnation procedure: Cohoused
- M/F ratio per cage: 1:2-3
- Verification of same strain and source of both sexes: Yes
- Proof of pregnancy: Sperm in vaginal smear referred to as Day 0 of gestation
- After confirmation of mating, females were returned to an individual cage. - Duration of treatment / exposure:
- Days 6-20 of gestation
- Frequency of treatment:
- 6 h/day
- Duration of test:
- Mated females were exposed 6 h/day on Days 6 through 20 of gestation.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 50, 100, 200 and 300 ppm
Basis:
nominal conc.
- No. of animals per sex per dose:
- 22 pregnant females per dose for 50, 100 and 200 ppm; 23 pregnant females per dose for control and high dose (300 ppm)
- Control animals:
- other: exposed concurrently to filtered room air
- Details on study design:
- - Rationale for animal assignment: Mated females were randomly assigned to treatment groups using a randomization system stratified by body weight on GD 0.
Examinations
- Maternal examinations:
- BODY WEIGHT: Yes
- Time schedule for examinations: GDs 0, 6, 13 and 21
FOOD CONSUMPTION
- Food consumption was measured for the intervals GDs 6-13 and 13-21.
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation Day 21; the females were killed with an intrapulmonary injection of T61 (Hoechst, Frankfurt, Germany) - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of resorptions: Yes - Fetal examinations:
- - Live fetuses were weighed and sexed.
- External examinations: Yes: [all per litter]
- Soft tissue examinations: Yes: [half per litter]; 50 % of the live fetuses were preserved in Bouin's solution and examined for internal soft-tissue changes.
- Skeletal examinations: Yes: [half per litter]; remaining fetuses were fixed in ethanol (70 %), eviscerated and then processed for skeletal staining with alizarin red S. - Statistics:
- The number of CL, implantation sites, and live fetuses, maternal food consumption and various body weights were analyzed by one way ANOVA, followed by Dunnett's-test. The percentage of non-live implant, resorptions, and males and the proportion of fetuses with alterations in each litter were evaluated by Kruskal-Wallis test followed by Dixon-Massey test. Rates of pregnancy and percentage of litters with any malformations or external, visceral, or skeletal variations were analyzed using Fisher's test. Where appropriate, least squares analysis was performed. The level of significance was p < 0.05.
- Indices:
- None
- Historical control data:
- Not applicable
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
All animals survived the exposure. Exposure to 300 ppm led to significant decreases in maternal weight gain and food consumption throughout exposure. Absolute weight gain was significantly reduced at 300 ppm.
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 200 ppm
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- >= 300 ppm
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
- There were no significant changes in number of implantations and live fetuses, in the incidence of non-live implants and resorptions, or in fetal weights across groups. One fetus of 200 ppm and two of the 300 ppm group showed different types of malformations. There was no consistent pattern of changes to suggest any treatment-related effects. The incidences of fetuses with external, visceral, and skeletal variations did not differ between the control and the treated groups.
- No significant increase in embryo/fetal lethality or fetal malformations were observed after exposure to methacrylic acid. While maternal toxicity was observed, methacrylic acid caused no evidence of developmental toxicity up to 300 ppm.
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
See the attached document for information on tables of results
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions, the No Observed Adverse Effect Level (NOAEL) of Methacrylic acid was considered to be 200 ppm for maternal toxicity and ≥ 300 ppm for developmental toxicity in Sprague-Dawley rats.
- Executive summary:
In a prenatal developmental toxicity study performed similarly to OECD Guideline 414, Methacrylic acid was administered via whole body inhalation to groups of mated female Sprague-Dawley rats (22-23/dose) at the dose levels of 0, 50, 100, 200 and 300 ppm from Days 6 to 20 of gestation. Maternal body weight and food consumption were recorded approximately once a week. On Day 21 of gestation, the dams were sacrificed and the gravid uterine weight, no. of corpora lutea, implantations, resorptions and dead and live fetus were recorded. Fetuses were sexed, weighed and examined for external, soft tissue and skeletal malformations.
All animals survived the exposure. Exposure to 300 ppm led to significant decreases in maternal weight gain and food consumption throughout exposure. Absolute weight gain was significantly reduced at 300 ppm. There were no significant changes in the number of implantations and live fetuses, in the incidence of non-live implants and resorptions, or in fetal body weights across groups. One fetus of the 200 ppm and two of the 300 ppm treated groups showed different types of malformations. There was no consistent pattern of change to suggest any treatment-related effects. The incidences of fetuses with external, visceral, and skeletal variations did not differ between the control and the treated groups.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.